References in periodicals archive ?
Only physicians experienced in immunosuppressive therapy and management of renal, cardiac or hepatic transplant patients should use CellCept.
6% of hepatic transplant patients receiving CellCept 3 g daily.
Infection and rejection of primary hepatic transplant in 93 consecutive patients treated with triple immunosuppressive therapy.
IMx Tacrolimus II vs Tacrolimus microparticle enzyme immunoassay evaluated in renal and hepatic transplant patients.
Finally, to evaluate the role of the type of organ transplanted in the correlation AxSYM/TDx, these methods were compared using 608 renal transplant and 112 hepatic transplant samples.
In addition, we compared the results obtained for 608 renal and 112 hepatic transplants using the AxSYM with those obtained using the TDx; the least-squares equations week y = (0.
IMx Tacrolimus II vs IMx Tacrolimus microparticle enzyme immunoassay evaluated in renal and hepatic transplant patients.
Correlation between the TAC I assay and the new TAC II assay in clinical practice has been evaluated with 70 whole-blood EDTA specimens obtained from kidney and hepatic transplant patients treated with tacrolimus.
The slope for the hepatic transplant samples was 0.
The influence of preservation injury on rejection in the hepatic transplant recipient.
Approximately 6,000 hepatic transplants are performed annually in the United States (U.
Ultrasound is a useful tool in imaging both renal and hepatic transplants.